GMCL1 Controls 53BP1 Stability and Modulates Taxane Sensitivity
Authors:
- Yuki KitoYKYuki Kito
- Tania J González-RoblesTGTania J González-Robles
- Sharon KaisariSKSharon Kaisari
- Juhee PaeJPJuhee Pae
- Sheena Faye GarciaSGSheena Faye Garcia
- Juliana Ortiz-PachecoJOJuliana Ortiz-Pacheco
- Beatrix UeberheideBUBeatrix Ueberheide
- Antonio MarzioAMAntonio Marzio
- Gergely RonaGRGergely Rona
- Michele PaganoMPMichele Pagano
Preprint
- 17 December 2025
- preprint
- Published by eLife Sciences Publications, Ltd in eLife preprints
Abstract
Mitotic surveillance pathways monitor the duration of mitosis (M phase) in the cell cycle. Prolonged M phase, caused by spindle attachment defects or microtubule-targeting drugs triggers formation of the ternary “mitotic stopwatch pathway” complex (MSP) consisting of 53BP1, USP28, and p53. This complex stabilizes p53, leading to cell cycle arrest or apoptosis in daughter cells. In cancers that are resistant to paclitaxel, a microtubule-targeting agent, cells bypass mitotic surveillance activation, allowing unchecked proliferation, although the underlying mechanisms remain poorly understood. Here, we identify GMCL1 as a key negative regulator of MSP signaling. We show that 53BP1 physically interacts with GMCL1, but not its paralog GMCL2, and we map their interaction domains. CRL3GMCL1 functions as a ubiquitin ligase that targets 53BP1 for degradation during the M phase, thereby reducing p53 accumulation in daughter cells. Depletion of GMCL1 inhibits cell cycle progression upon release from prolonged mitotic arrest, a defect that is rescued by co-silencing 53BP1 or USP28. Moreover, GMCL1 depletion sensitizes cancer cells to paclitaxel in a p53-dependent manner. Together, our findings support a model in which dysregulated CRL3GMCL1-mediated degradation of 53BP1 prevents proper MSP function, leading to p53 degradation and continued proliferation. Targeting GMCL1 may therefore represent one possible avenue for addressing paclitaxel resistance in cancer cells with functional p53.Keywords
All Related Versions
Funding Information
- HHS | NIH | NIH Office of the Director (R35-GM136250)
- MEXT | Japan Society for the Promotion of Science
- Uehara Memorial Foundation
- HHS | NIH | NIH Office of the Director (T32GM136542)
- Howard Hughes Medical Institute (GT15758)
- HHS | NIH | National Institute of General Medical Sciences (1K99GM155613-01A1)
- Life Sciences Research Foundation
- European Molecular Biology Organization
- U.S. Department of War (HT9425-24-1-0019)
- HHS | NIH | National Cancer Institute (R01 CA296867-01A1)
- Magyar Tudományos Akadémia (LP2023-15/2023)
- European Molecular Biology Organization (IG5670-2024)
- Hungarian Research Network (KSZF-143/2023)
- HHS | NIH | National Cancer Institute (P30CA016087)
This publication has 40 references indexed in Scilit:
- Prolonged mitosis: A key indicator for detecting stressed and damaged cellsCurrent Opinion in Cell Biology, 2024
- CDK-independent role of D-type cyclins in regulating DNA mismatch repairMolecular Cell, 2024
- BTB domains: A structural view of evolution, multimerization, and protein–protein interactionsBioEssays, 2022
- Pan-cancer proteomic map of 949 human cell linesCancer Cell, 2022
- Intrinsically disordered substrates dictate SPOP subnuclear localization and ubiquitination activityJournal of Biological Chemistry, 2021
- Taxanes in cancer treatment: Activity, chemoresistance and its overcomingDrug Resistance Updates, 2021
- GCL and CUL3 Control the Switch between Cell Lineages by Mediating Localized Degradation of an RTKDevelopmental Cell, 2017
- Dephosphorylation Enables the Recruitment of 53BP1 to Double-Strand DNA BreaksMolecular Cell, 2014
- Prolonged Prometaphase Blocks Daughter Cell Proliferation Despite Normal Completion of MitosisCurrent Biology, 2010
- The germ cell-less gene product: A posteriorly localized component necessary for germ cell development in DrosophilaCell, 1992